Orchid Buys Karalex Pharma for Generics Marketing Presence in the US

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 13 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1373     ISSN: 1756-7874

Section: Mergers & Acquisitions



Orchid Chemicals & Pharmaceuticals has established a direct marketing facility in the US for its generic products by acquiring Karalex Pharma, a US-based generic marketing and sales service provider...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details